In last trading session, Oncolytics Biotech, Inc (NASDAQ:ONCY) saw 0.38 million shares changing hands with its beta currently measuring 1.68. Company’s recent per share price level of $1.07 trading at $0.0 or 0.00% at ring of the bell on the day assigns it a market valuation of $115.48M. That closing price of ONCY’s stock is at a discount of -63.55% from its 52-week high price of $1.75 and is indicating a premium of 21.5% from its 52-week low price of $0.84. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.31 million shares which gives us an average trading volume of 422.78K if we extend that period to 3-months.
For Oncolytics Biotech, Inc (ONCY), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.12. Splitting up the data highlights that, out of 1 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 1 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -0.07 in the current quarter.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Oncolytics Biotech, Inc (NASDAQ:ONCY) trade information
Oncolytics Biotech, Inc’s shares saw a change of -20.74% in year-to-date performance and have moved -9.32% in past 5-day. Oncolytics Biotech, Inc (NASDAQ:ONCY) showed a performance of -13.71% in past 30-days. Number of shares sold short was 2.65 million shares which calculate 3.57 days to cover the short interests.
Oncolytics Biotech, Inc (ONCY) estimates and forecasts
Statistics highlight that Oncolytics Biotech, Inc is scoring comparatively lower than the scores of other players of the relevant industry. The company lost -8.55% of value to its shares in past 6 months, showing an annual growth rate of 3.33% while that of industry is 16.60. Apart from that, the company came raising its revenue forecast for fiscal year 2024.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 18.01% during past 5 years.
Oncolytics Biotech, Inc (NASDAQ:ONCY)’s Major holders
Insiders are in possession of 3.82% of company’s total shares while institution are holding 1.75 percent of that, with stock having share float percentage of 1.82%. Investors also watch the number of corporate investors in a company very closely, which is 1.75% institutions for Oncolytics Biotech, Inc that are currently holding shares of the company. INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC is the top institutional holder at ONCY for having 0.2 million shares of worth $0.2 million. And as of 2024-06-30, it was holding 0.2637 of the company’s outstanding shares.
The second largest institutional holder is SEEDS INVESTOR LLC, which was holding about 0.19 million shares on 2024-06-30. The number of shares represents firm’s hold over 0.2524 of outstanding shares, having a total worth of $0.19 million.
